This Viewpoint discusses serious adverse events linked to interactions between therapists and patients in trials of psychedelic-assisted therapy.
No takes yet. Share an insight, caveat, or question.
McNamee et al. (2023) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: